Illumina told shareholders that Carl Icahn’s board nominees would “threaten the progress” of the biotech company’s core business.
Vistry named ValueAct founder Jeff Ubben as a nonexecutive director and two other board members stepped down on Wednesday.
A fight has broken out between veteran activist Carl Icahn and biotech company Illumina as the investor nominates three candidates to the board.
Hoffman cited a desire to invest in companies using OpenAI’s software, which would cause a conflict of interest, he said in the post.
Elon Musk remarked that he wouldn’t mind Tesla going bankrupt, if it means a rival company builds a better car, according to a company board member.
In December, Starboard nominated four directors for election to the board at materials company Rogers.
Salesforce is appointing three new directors to its board, including ValueAct’s Mason Morfit.
Activist investor Nelson Peltz wants a Disney board seat, but his argument should be focused on succession planning rather than stock performance.
WWE has confirmed that former CEO Vince McMahon will return to the company’s board.
The shipping company could benefit from a slimmed-down structure and tweaks to its board.
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}